Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy - Döhner, Hartmut; Lübbert, Michael; Fiedler, Walter; Fouillard, Loic; Haaland, Alf; Brandwein, Joseph M.; Lepretre, Stephane; Reman, Oumedaly; Turlure, Pascal; Ottmann, Oliver G.; Müller-Tidow, Carsten; Krämer, Alwin; et al. (Blood, 2014)
Gesehen am 27.07.2020